Hepatitis B Infection in Pregnancy-Experience at a Tertiary Care Centre of North India
DOI:
https://doi.org/10.12974/2312-5411.2017.04.5Keywords:
Hepatitis B, HbsAg, HBV DNA Quantitative, Pregnancy.Abstract
Objectives: To investigate the Seroprevalence of hepatitis B surface antigen in pregnant women and managing chronic HBV infection in pregnant women for preventing mother to child transmission.
Methods: Fifteen thousand pregnant women were evaluated using history, examination and test for serum HbsAg and who were found to be HbsAg positive underwent liver function tests, HbeAg and HBV DNA analysis by Polymerase Chain Reaction (PCR).
Results: out of fifteen thousand (15000) women, 52 women tested positive for HbsAg. Of these, 8(15.38%) presented with acute hepatitis and 44(84.6%) were asymptomatic carriers. The highest HbsAg positivity was seen in age group of 20-25 years and maximum women were multiparous (67.23%). Assessment of risk factors revealed history of tattooing in 22 women (42.3%). Out of 52 women, 12 patients tested positive for HbeAg and their DNA tires were more than one Lakh copies/ml. Forty six women(88.4%) delivered vaginally and rest 6(11.5%) underwent cesarean section which was mainly done for obstetric indications. All the babies born received immunoglobulin and first dose of HBV vaccine within 12 hours of birth.
Conclusion: Seroprevalence of HbsAg in antenatal women was found to be 0.34%.
References
Zhang SL, Yue YF, Bai GQ, Shi L and Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004; 10: 437-8. https://doi.org/10.3748/wjg.v10.i3.437
Beasley RP and Hwang LY. Postnatal infectivity of hepatitis surface antigen-carrier mothers. J Infect Dis 1983; 147: 185-190. https://doi.org/10.1093/infdis/147.2.185
Yang X, Cui MX and LIU BG. Breast-feeding by mothers with positive serum hepatitis B virus test. Zhonghua Fu Chan Ke Za Zhi 1994; 29: 586-8.
Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34(Suppl 1): S1-3. https://doi.org/10.1016/S1386-6532(05)00384-7
Tan J, Surti B and Saab S. Pregnancy and cirrhosis. Liver Transpl 2008; 14: 1081-91. https://doi.org/10.1002/lt.21572
Wong S, Chan LY, Yu V and Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999; 16: 485-8. https://doi.org/10.1055/s-1999-6802
Tse KY, Ho LF and Lao T. The impact of maternal HbsAg carrier status on pregnancy outcomes: a case control study. J Hepatol 2005; 43: 771-5. https://doi.org/10.1016/j.jhep.2005.05.023
MacLean B, Hess RF, Bonvillain E, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J 2012; 102: 47-9.
Pastorek JG, Miller JM and Summers PR. The effect of hepatitis B antigenemia on pregnancy outcome. AJOG 1988; 158: 486-9. https://doi.org/10.1016/0002-9378(88)90010-5
Tse KY, Ho LF and Lao T. The impact of maternal HbsAg carrier status on pregnancy outcome. J Hepatol 2005; 43: 771-5. https://doi.org/10.1016/j.jhep.2005.05.023
Lert-amornpong S, Caengow S and Chutaputti A. The association of pregnancy outcomes and HbsAg positive. Thai J Gastroenterol 2007; 8(3): 115-8.
Nayak NC, Panda SK, Zuckerman AJ, et al. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J med Virol 1987; 21: 137-145. https://doi.org/10.1002/jmv.1890210205
Panda SK, Ramesh R, Rao KV, et al. Comparative evaluation of the immunogenicity of yeastderived( recombinant) and plasma-derived hepatitis B vaccine in infants. J Med Virol 1991; 35: 297-302. https://doi.org/10.1002/jmv.1890350416
Gill HH, Majumdar PD, Dhunjiboy KR, et al. Prevalence of hepatitis B e antigen in pregnant women and patient with liver disease. J Assoc Physicians India 1985; 43:247-8.
Dwivedi M, Misra SP, Misra V, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011; 30(2): 66-71. https://doi.org/10.1007/s12664-011-0083-y
